The clinical question is whether a VR strategy is equal to or better than a more conventional active intervention. As an aside, how will FNIRS be used in subjects whose M1S1 is included within the infarction zone? Inclusion/exclusion criteria: no mention of chronicity. Given that spontaneous recovery can occur during the first few months, this is a factor to consider for study inclusion, and also for randomization. Randomization plan: the inclusion/exclusion criteria is quite broad, and so there is a possibility that participants will be unevenly distributed between treatment vs control. Namely, chronicity and level of impairment (example: presence of finger extension and abduction are generally considered to be predictive of recovery) are not taken into consideration. Dose: please provide rationale for why 43 min sessions 2x a week for 8 weeks was chosen Outcome measure: the authors mention that the purpose of the intervention is to improve active and passive range of motion (AROM/PROM). However, AROM and PROM are missing from the outcome measures. UE-FM is a measure of selective control, not range of motion and strength.
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GENERAL COMMENTS
Thank you for submitting this paper. This is an interesting protocol for a RCT in stroke survivors. The proposed outcomes and methodology appears appropriate. The same size is justified although appears a little small (n=20 in each group after drop out) to allow generalisability, especially as the stroke survivors recruited are likely to have diverse strokes and be varying times post nadir.
It would be worth considering stratifying the population with regards to time since stroke; those only weeks or months after stroke are likely to have a greater trajectory of recovery than those several years after stroke and uneven allocation between UC and expt. groups could confound the results. I would also advise considering shoulder pain as either a controlled or exclusion variable, as this is a common sequelae after stroke, could precipitate an adverse event and may limit adherence to the intervention.
Finally, I suggest including some methods of allowing participants to give their feedback on the intervention; much of the technology being used is in its infancy and it would be helpful for future work and clinical practice to know what participants liked/didn't like. 1. Although the online platform may be novel, the study isn't particularly innovative, as it is simply testing an adaptable gaming system compared to no care. Given that most rehabilitation researchers will generally agree that some amount of rehab practice is superior to no care, the lack of intervention for the control group is problematic. Indeed, the introduction stresses the finding that virtual reality therapy meta-analyses show VR to be similar in outcomes to standard rehabilitation for treatment of UE impairment and disabilities. So why compare VR to nothing? This choice also introduces a clear bias. There is no entry criteria about the time since onset of stroke, so one assumes that participants can be from 1 week to 10 years post hemiparesis. Those with more chronic impairment have not likely tried to practice with the affected hand and may have declined in motor control from lack of use. Assigning them to an active strategy is likely to reinforce use and lead to gains, whereas the usual care group will continue to stay at their plateau. Setting the gains that you think are important is not a solution. One solution could be that all participants receive a few weeks of conventional UE rehabilitation at entry to raise all to a more meaningful, stable baseline, prior to randomization.
REVIEWER
Response: We appreciate the Reviewer's comments.
We have made three important changes in the manuscript that we believe go some way to mediate the issue of bias as you have suggested. We have 1) introduced inclusion criteria that the participant must be at least 3 months post-stroke (Page 4), 2) introduced inclusion criteria that the participant must demonstrate a motor evoked potential (MEP) from the first dorsal interosseous muscle of the paretic hand in at least 5 out of 10 pulses during resting state transcranial magnetic stimulation (TMS) (Page 4), and 3) provided further details regarding the activity of the usual care control group (Page 6), which, in short, encourages the participants to maintain their daily routine and any existing therapy.
2. As an outcome measure for mildly affected UE motor control, the F-M scale presents a likely ceiling effect for change.
Response: We agree that using the F-M scale for the measurement of upper extremity (UE) motor control is somewhat problematic given the potential for ceiling effects. However, it is a widely used scale that has been recommended in the recently published 'Standardized measurement of sensorimotor recovery in stroke trials: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable' (Kwakkel et al. International Journal of Stroke 2017;12(5):451-61) as a measure of body function. But given the reviewers concerns, we have added the Action Research Arm Test as a joint primary outcome in the revised protocol (Page 6), which was the consensus measure of UE activity limitation in the aforementioned publication.
3. The MAS is not a very meaningful or changing measure for those with mild to mod impairment of motor control.
Response: We acknowledge that the MAS is an imperfect measure of spasticity after stroke, for the reasons mentioned, and others, including questionable discriminative ability and no evidence of being correlated with reflexive activity (Aloraini et al. Assessment of spasticity after stroke using clinical measures: a systematic review. Disability and Rehabilitation 2015;37(25):2313-23). However, the MAS remains a most commonly used measure of upper extremity spasticity, and as stated in the aforementioned publication, there is insufficient "psychometric evidence to recommend one tool over the others". As such, we believe the MAS is a viable measure of post-stroke spasticity in this study.
4. There is little justification for using FNIRS as a secondary measure of cortical activation during UE movement. As an aside, how will FNIRS be used in subjects whose M1S1 is included within the infarction zone?
Response: We have included a paragraph within the introduction (Pages 3-4) to justify the inclusion of fNIRS as a secondary outcome measure. Whilst it is possible that the M1S1 may fall within the infarct zone, the area that the fNIRS optodes cover over the left and right hemisphere is 36cm2 (6cm x 6cm) of each hemisphere. Unless the area of infarct is larger than 36cm2, we are confident that the array of fNIRS optodes will detect changes in cortical haemodynamic responses of adjacent cortical areas.
5. A pre-and post-intervention study will not provide insight into mechanisms that relate to failure to improve or an improvement in one group. The clinical question is whether a VR strategy is equal to or better than a more conventional active intervention.
Response: We agree that this study will not provide insights into the mechanisms for improvement post-stroke and have subsequently changed the relevant statement to read "Clinical and neurophysiological measures will determine functional and associated cortical changes in response to virtual therapy post-stroke." (Page 2). 6. Inclusion/exclusion criteria: no mention of chronicity. Given that spontaneous recovery can occur during the first few months, this is a factor to consider for study inclusion, and also for randomization.
Response: We acknowledge the potential for spontaneous recovery in the first 3 months after stroke has the potential to confound our results. We have therefore added to the inclusion criteria that the participants must be at least 3 months post-stroke (Page 4).
7. Randomization plan: the inclusion/exclusion criteria is quite broad, and so there is a possibility that participants will be unevenly distributed between treatment vs control. Namely, chronicity and level of impairment (example: presence of finger extension and abduction are generally considered to be predictive of recovery) are not taken into consideration.
Response: As noted above, we have added to the inclusion criteria that participants will be included only if they are at least 3 months post-stroke (Page 4). We have also added inclusion criteria that participants must be able to produce a clear MEP from the first dorsal interosseous muscle of the paretic hand elicited through TMS (Page 4).
8. Dose: please provide rationale for why 43 min sessions 2x a week for 8 weeks was chosen
Response: The development of the intervention dose was guided primarily by the Laver et al. (2015) Cochrane Database Systematic Review 'Virtual reality for stroke rehabilitation'. In this review, the authors reported that when the effects of virtual reality intervention were compared with no intervention or when it was used to augment standard care, trials with less than 15 hours of intervention had a significant effect on upper extremity function, but trials providing more than 15 hours of intervention did not have a significant effect. In STRIVE, the participants will receive between 12 and 16 hours of VR therapy. 342-354), we felt the development of the intervention in this study would be best served by looking to the field of VR and its effects on stroke rehabilitation outcomes.
9. Outcome measure: the authors mention that the purpose of the intervention is to improve active and passive range of motion (AROM/PROM). However, AROM and PROM are missing from the outcome measures. UE-FM is a measure of selective control, not range of motion and strength.
Response: We have modified the text in question (Page 5), as the Reviewer correctly notes that we are not targeting AROM/PROM or muscle strength as outcomes in this study. However, the Jintronix Rehabilitation System does assess the participants AROM so as to establish their baseline ROM, which is then used in the prescription of exercises that are tailored to the participants ROM.
Reviewer #2
Comment: Thank you for submitting this paper. This is an interesting protocol for a RCT in stroke survivors. The proposed outcomes and methodology appears appropriate. The same size is justified although appears a little small (n=20 in each group after drop out) to allow generalisability, especially as the stroke survivors recruited are likely to have diverse strokes and be varying times post nadir.
1. It would be worth considering stratifying the population with regards to time since stroke; those only weeks or months after stroke are likely to have a greater trajectory of recovery than those several years after stroke and uneven allocation between UC and expt. groups could confound the results.
Response: Please refer to the response to Reviewer 1 (item 7). In brief, we have added to the inclusion criteria that participants will be included only if they are at least 3 months post-stroke (Page 4).
2. I would also advise considering shoulder pain as either a controlled or exclusion variable, as this is a common sequelae after stroke, could precipitate an adverse event and may limit adherence to the intervention.
Response: We agree that shoulder pain may confound our results and limit intervention adherence if it is not controlled for in this study. We have therefore included the following to our exclusion criteria: "Participants will be excluded from the study if they have… 3) upper-extremity joint pain that would limit their ability to complete the trial." (Page 4) 3. Finally, I suggest including some methods of allowing participants to give their feedback on the intervention; much of the technology being used is in its infancy and it would be helpful for future work and clinical practice to know what participants liked/didn't like.
Response: We intend to undertake a qualitative study to determine the barriers, motivations and acceptability of the intervention in community-dwelling stroke survivors. Due to this component of the study requiring separate ethics approval from the approving ethics board, and the need to complete this study in a timely manner as per the requirements of the funding body, we have chosen to not include details of the qualitative study here.
Reviewer #3
Comment: I read this research protocol with interest. A little bit more detail around the intervention itself (and control) would enhance reproducibility. I have jotted down ideas for consideration by authors -mainly to explain rationale for different aspects of the study.
1. Is the research Q: is VT more effective than usual care (=no rehab?) for people with mild-tomoderate UL impairment? Is there a need for this seeing as we know that VT is equivalent to usual rehab (so you are planning to compare rehab via VT to no rehab)? Or is there a Q that UL rehab may not be any more effective than no therapy?
Response: The primary intention for this study was to determine if a group of community-based stroke survivors would improve UE function following participation in a VT training intervention using the Jintronix platform, compared to a group that did not complete the training intervention. This question has not been asked before, and we believe this study is a necessary and pragmatic approach to establishing the potential feasibility and efficacy of this gaming platform in a community-based setting for stroke survivors. We acknowledge that our description of 'usual care' in the initial manuscript did not adequately describe what it would entail. We have therefore clarified what usual care is in this study in this revised manuscript (Page 6). Usual care is not necessarily no rehabilitation, as you suggested, but rather the usual care control group are requested to maintain their daily routine and any existing therapy.
2. In intro you state: "online VT systems can be easily implemented in a stroke survivor's home or at a local community centre… has the potential to reduce… potential difficulties experienced by SSs travelling long distances to outpatient appointments or with limited access to transportation" So why is the intervention being delivered in a community centre rather than at participants homes?
Response: We have altered the text to better reflect our aim here, that is, to suggest that a local, community-based rehabilitation service/option would be advantageous for the reasons listed. (Page 3) 3. Intervention: 2 x 45 min sessions, over 8 weeks. Is there a rationale that this dose will be enough? It seems that lately there have been numerous trials coming out with equivocal results for ULs poststroke -have they informed your intervention design?
Response: Please refer to our response to Reviewer 1 (item 8).
4. Consider the recommendations from expert consensus on stroke rehabilitation research intervention design (Walker et al 2017, International Journal of Stroke) -more detail would be ideal regarding why you think eg dose of intervention will work? What exactly is usual care? How will the exercise program be progressed (is there some form of algorithm?) Will participants have any say at all in their exercise selection? Will exercises be conducted in sitting or standing? How experienced are the exercise physiologists in prescribing exercises for UL for people with stroke? (And is there a reason for using exercise physiologists -I am more familiar with reading about exercises provided by OTs or PTs for stroke-affected ULs, so an explanation here could be useful). , approximately 15 hrs of total therapy time was reported to be sufficient to improve motor function using VT. In our trial, we estimate that all participants will receive between 12 to 16 hrs of VT, which falls within the optimal dose reported by Laver and colleagues.
Usual care -Please refer to item 5 below for our clarification of usual care.
Exercise progression -After each training session, a score will be presented to the participant, and the remotely located exercise physiologist, indicating the level of success for each exercise completed. If a participant is able to achieve at least 80% success for 2 consecutive exercise sessions for a particular exercise, the difficulty of that exercise will be increased by 10% (the Jintronix software only allows for 10% increments). If a participant achieves a score of less than 50% in 2 consecutive exercise sessions for a particular exercise, the level of difficulty for that particular exercise will be reduced by 10%.
Participant input -All exercise prescribed will be tailored to the level of impairment and active range of motion of the paretic arm. During the first session of the participants training, they will be asked to provide feedback on their preference and capacity to perform the prescribed exercises. If they have specific doubts or issues with the prescribed exercises, an alternative exercise will be selected in consultation with the participant.
Conducted sitting or standing -As the focus of this project is the upper extremity, participants that are wheelchair-bound or have difficulties standing for long periods of time may perform the exercises while seated. The Jintronix system is capable of detecting movement of the upper-extremity either standing or sitting.
Experience of exercise physiologist -The exercise physiologist involved in this trial will have at least two year experience working with people with neurological impairments and brain injuries.
5. Can you define usual care -I think this equates to no therapy -will you be asking participants to NOT eg commence private UL therapy over course of the trial/intervention period?
Response: We have defined usual care, in the context of this study, to be maintaining their usual routine as per normal before enrolling into the trial. Therefore, if any participant has already commenced UE therapy before the trial, we would advise them to continue on with therapy, but not change their routine (i.e. intensity, frequency and duration). We will not request participants to not commence UE therapy external to this study, but we will request participants inform the investigators of any changes to their usual care and therapy practices that may occur during the study. The level of activity performed each week outside of the trial will be documented by the MAL-28 to control for any variances in UL motor activity. We have also replaced the Stroke-Specific Quality of Life Scale with the EQ-5D-5L as recommended in the aforementioned publication.
7. Given you are measuring cortical haemodynamics, a mention of this in introduction is warranted
Response: We have added the following paragraph regarding the use of fNIRS to measure cortical haemodynamics following stroke in the introduction:
To understand the effects of VT on cerebral activity in stroke rehabilitation, neuroimaging techniques such as functional magnetic resonance imaging (fMRI) have been used previously to determine cortical reorganisation post-rehabilitation.16 While fMRI is considered gold-standard measures in neuroimaging, these techniques may be limited as they only allow for small movements to occur within the scanner that are very different from daily life. In this sense, functional near-infrared spectroscopy (fNIRS) may be a more suitable neuroimaging technique as it is able to measure changes in cerebral haemodynamic responses (i.e. changes in oxy-and deoxy-haemoglobin [HbO2 and HHb]) in response to larger body and head movements that mimic activities of daily living. Previous studies have also established that the measures from fNIRS are highly comparable with blood oxygen-level dependent (BOLD) signals from fMRI,17 18 which makes it a suitable surrogate to changes in brain activity following VT in people with stroke.
8. What is the rationale for having an exercise physiologist present but not participating in therapy supervision -I don't understand how interaction between the EP and participant would confound outcome measurement (happens at a different site with a different person?). It might be useful to collect data on how much help the participants require to be able to use/set-up the equipment particularly if this looks effective and you want to scale this up further in the future, or be able to deliver therapy in the home setting. I.e. can participants set up the equipment, or will they always need a trained professional to set it up etc.
Response: As mentioned above (Reviewer 2, item 3), a qualitative study will be run parallel to this study, but it will be executed as a separate study. We believe the interaction between the exercise physiologist and the participants may influence some of the intended outcomes included in the qualitative study, and thus confound the results of that study. We have modified the text in this manuscript to clarify this issue.
